Antiretroviral therapy (ART) uses a combination of drugs to reduce the replicability of HIV. Thus, with advances in
antiretroviral therapy, treating and managing HIV has significantly improved. When HIV is well-controlled with ART, the immune system is better supported, reducing the risk of opportunistic infections and associated complications, including heart attack. However, the virus
persists and is produced at low levels even after ART. Hence, patients are still at high risk for cardiovascular health conditions even with treatment, so paying close attention to health biomarkers is crucial.